Answer
Yes, AdreView (iobenguane) is contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1.
Sources for this answer
- AdreView 74 MBq/mL Solution for InjectionGE Healthcare Limited · emc · SmPC §4.3 Contraindications · Version 1Document updated
Sources checked